|  Help  |  About  |  Contact Us

Publication : ILC3s control airway inflammation by limiting T cell responses to allergens and microbes.

First Author  Teng F Year  2021
Journal  Cell Rep Volume  37
Issue  8 Pages  110051
PubMed ID  34818549 Mgi Jnum  J:334441
Mgi Id  MGI:6881837 Doi  10.1016/j.celrep.2021.110051
Citation  Teng F, et al. (2021) ILC3s control airway inflammation by limiting T cell responses to allergens and microbes. Cell Rep 37(8):110051
abstractText  Group 3 innate lymphoid cells (ILC3s) critically regulate host-microbe interactions in the gastrointestinal tract, but their role in the airway remains poorly understood. Here, we demonstrate that lymphoid-tissue-inducer (LTi)-like ILC3s are enriched in the lung-draining lymph nodes of healthy mice and humans. These ILC3s abundantly express major histocompatibility complex class II (MHC class II) and functionally restrict the expansion of allergen-specific CD4(+) T cells upon experimental airway challenge. In a mouse model of house-dust-mite-induced allergic airway inflammation, MHC class II(+) ILC3s limit T helper type 2 (Th2) cell responses, eosinophilia, and airway hyperresponsiveness. Furthermore, MHC class II(+) ILC3s limit a concomitant Th17 cell response and airway neutrophilia. This exacerbated Th17 cell response requires exposure of the lung to microbial stimuli, which can be found associated with house dust mites. These findings demonstrate a critical role for antigen-presenting ILC3s in orchestrating immune tolerance in the airway by restricting pro-inflammatory T cell responses to both allergens and microbes.
Quick Links:
 
Quick Links:
 

Expression

Publication --> Expression annotations

 

Other

14 Bio Entities

Trail: Publication

0 Expression